InvestorsHub Logo
Followers 14
Posts 2307
Boards Moderated 0
Alias Born 01/02/2003

Re: bb8675309 post# 298644

Friday, 02/12/2021 1:59:41 PM

Friday, February 12, 2021 1:59:41 PM

Post# of 462172
bb8675309, yes...Dr.M said "...planning to present on a relatively short notice" . He also said in the context of being ahead of Cassava for ALZ phase 3 "...Parkinson's disease dementia data which also is unique for Anavex". So, those are pretty strong and definitive statements considering the fact he called the ALZ trial as PIVOTAL .
He also stressed that "...and the other point I tried to make is that we have the program in Rett syndrome, which could generate revenue pretty soon by itself".

We are in for significant appreciation for AVXL.

-vg_future
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News